Glioma IL13Rα2 is associated with mesenchymal signature gene expression and poor patient prognosis.

Glioma IL13Rα2 is associated with mesenchymal signature gene expression and poor patient prognosis.

A major challenge for successful immunotherapy against glioma is the identification and characterization of validated targets. We have taken a bioinformatics approach towards understanding the biological context of IL-13 receptor α2 (IL13Rα2) expression in brain tumors, and its functional significan...

Full description

Bibliographic Details
Main Authors: Christine E Brown, Charles D Warden, Renate Starr, Xutao Deng, Behnam Badie, Yate-Ching Yuan, Stephen J Forman, Michael E Barish
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3800130?pdf=render

Internet

http://europepmc.org/articles/PMC3800130?pdf=render

Similar Items